New Delhi [India], January 16 (ANI/SRV): Indic Center for Psychological Wellness and Holistic Health, a one-stop solution for therapy and psychometric counseling, has shared its plan of expanding nationwide with multiple operational branches. Indic Center will be the first company to establi
Delhi Deputy Chief Minister Manish Sisodia wrote to the Delhi LG VK Saxena, demanding action against certain officers of the government. In the letter, he recommended suspension and FIR against officers who deliberately stopped funds for Mohalla Clinics in October and November before the MCD
Researchers found that neuroimaging technology has great promise in assisting clinicians in the identification of specific symptoms of mental health disorders that are associated with abnormal patterns of brain activity.
New Delhi [India], January 11 (ANI/PNN): Gytree.com announced its first round of fundraising, led by Biocon's Kiran Mazumdar Shaw, Rainmatter Investments, Ajay Srinivasan former CEO of Aditya Birla Capital, Anubhuti Sharma of San Francisco-based Millie Clinic amongst others.
Geneva [Switzerland], January 11 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.
New Delhi [India], January 10 (ANI/QIMN): A span-new wellness company headquartered in Hyderabad, DERMALOGY seeks to empower people to disregard societal notions and prioritise their personal wellbeing. Established in 2022, after the products were clinically tested and approved by Dermatolog
The plea stated that at present cardiac stents or coronary stents are allowed to be manufactured or imported and sold, without or with negligible supporting clinical study or data, and merely based on predicate (device or literature), submitted by the manufacturer or importer.
A study published in Clinical Gastroenterology and Hepatology by Keck Medicine at USC provides more motivation for people to minimise their fast-food consumption.
A release said that Covaxin has been demonstrated in clinical trials to generate a broader immune response "against the whole virus covering important antigens such as S-protein, RBD, and N-protein whereas currently approved vaccines in the US target only S-protein antigen"